Takeover of pharmaceutical site in Saint Germain-Laprade

A new site entered the FAREVA GROUP, on September 1st, 2015, with the takeover of the Merck Sharp & Dohme plant in St-Germain-Laprade.

With 130 people, this site, specialized in the Active Pharmaceutical Ingredient (API) enables FAREVA to double its production capacity distributed, at present, between its French sites, in Val de Reuil and Romainville, and Feucht in Germany.

Investments of 25 million € are planned for the future developments. They concern the setting-up of highly active molecules intended, in particular, for anticancer medicine. The development of a very sought out technology which makes chemical reactions at very low temperatures possible (-60° C) is also intended.

Its putting into service is expected in 2017.